Lapatinib Completed Phase 4 Trials for Malignancies Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01328054A Study in Cancer Patients to Evaluate the Effect of Lapatinib on the QTc Interval